This inventor holds 4 USPTO granted patents. Top assignee: Sorrento Therapeutics, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Min Soo Kim: Innovator in Antibody Development
Introduction
Min Soo Kim is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 4 patents, his work focuses on enhancing immune responses for therapeutic applications.
Latest Patents
One of his latest patents involves the creation of variant antibodies that bind OX40. This patent describes how these variant anti-OX40 antibodies mimic the activity of OX40L, acting as an agonist against the OX40 receptor. This innovation enhances T cell clonal expansion and differentiation. The variant antibodies exhibit improved binding affinity for OX40 and demonstrate enhanced agonistic activity compared to the wild type anti-OX40 antibody from which they are derived. These antibodies specifically bind to OX40 receptors on activated T lymphocytes, stimulating the proliferation of effector T cells and promoting cytokine production.
Another significant patent by Min Soo Kim is related to anti-KRAS binding proteins. This patent provides anti-KRAS antibodies and their antigen-binding fragments, which are utilized in cancer treatment. These advancements represent a crucial step in developing targeted therapies for cancer patients.
Career Highlights
Min Soo Kim is currently associated with Sorrento Therapeutics, Inc., where he continues to innovate in the field of antibody research. His work has been instrumental in advancing therapeutic options for various diseases, particularly cancer.
Collaborations
He collaborates with talented professionals in his field, including his coworker Heyue Zhou. Their combined expertise contributes to the ongoing success of their projects and the development of groundbreaking therapies.
Conclusion
Min Soo Kim's contributions to antibody development are noteworthy and impactful. His innovative patents and ongoing work at Sorrento Therapeutics, Inc. highlight his commitment to advancing medical science. His research continues to pave the way for new therapeutic strategies in the fight against cancer and other diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile